ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 854,92
0,00%
Dow Jones
44 421,91
-0,28%
DAX
21 428,24
-1,30%
Brent Oil
75,115
-0,33%
Bitcoin
99 609,03
-1,79%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE

  6. Revvity Inc (RVTY) Cours

Revvity Inc

Revvity Inc (RVTY)

NYSE
123,69
-2,44
(-1,93%)
Fermé 04 Février 10:00PM
Retardé de 15 minutes
123,69
0,00
(0,00%)
Après les heures de négociation: 1:48AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
123,69
Prix Achat
-
Prix Vente
-
Volume échangé
850 240
123,13 Fourchette du Jour 126,57
97,315 Plage de 52 semaines 133,96
Cap du marché
15,053B
Clôture Veille
126,13
Ouverture
125,74
Dernière Transaction
127553
@
123.69
Dernière heure de transaction
Volume financier
US$ 106 232 650
VWAP
124,9443
Volume moyen (3 m)
893 781
Actions en circulation
121 702 145
Rendement du Dividende
0.23%
Ratio Cours sur Bénéfices
21,73
Bénéfice par action (BPA)
5,7
Chiffre d'affairess
2,75B
Bénéfice net
693,09M

À propos de Revvity Inc

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and di... PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software. Show more

Secteur
Lab Analytical Instruments
Industrie
Engineering Services
Site Web
www.perkinelmer.com
Siège social
Waltham, Massachusetts, USA
Fondé
2001
Revvity Inc est coté dans le secteur Lab Analytical Instruments de la New York Stock Exchange avec le ticker RVTY. Le dernier cours de clôture d'Revvity était de US$126,13. Au cours de la dernière année, les actions de Revvity ont été négociées dans une fourchette de prix de US$ 97,315 à US$ 133,96.

Revvity compte actuellement 121 702 145 actions en circulation. La capitalisation boursière d'Revvity est de US$15,35 milliard. Revvity a un ratio cours/bénéfice (ratio PE) de 21.73.

RVTY Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

31 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

31 Janvier 2025
Edgar (US Regulatory)

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Fourth quarter revenue of $729 million; 5% reported growth; 6% organic growth Fourth quarter GAAP EPS of $0.78; Adjusted EPS from continuing operations of $1.42 Initiates full year 2025 guidance...

31 Janvier 2025
Business Wire

Form 144 - Report of proposed sale of securities

30 Janvier 2025
Edgar (US Regulatory)

Revvity Board Declares Quarterly Dividend

The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on May 9, 2025 to all shareholders of...

23 Janvier 2025
Business Wire

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences...

13 Janvier 2025
Business Wire

Form 8-K - Current report

13 Janvier 2025
Edgar (US Regulatory)

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2024 financial results prior to market open on Friday, January 31, 2025. The Company will host a...

12 Janvier 2025
Business Wire

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN’s automated chemiluminescence-based immunoassay...

10 Janvier 2025
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

08 Janvier 2025
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.47-0.378543814433124.16128.285121.561206854125.39594881CS
410.198.97797356828113.5128.285113.48937568121.95872032CS
122.141.76059234883121.55128.285107.17893781116.72591888CS
260.009999999999990.00808538163001123.68133.96107.17790384119.05385855CS
5218.6117.7103159498105.08133.9697.315837007113.15046649CS
1567.356.31768953069116.34133.9679.5824325110.82598074CS
2607.356.31768953069116.34133.9679.5824325110.82598074CS

RVTY - Frequently Asked Questions (FAQ)

What is the current Revvity share price?
The current share price of Revvity is US$ 123,69
How many Revvity shares are in issue?
Revvity has 121 702 145 shares in issue
What is the market cap of Revvity?
The market capitalisation of Revvity is USD 15,35B
What is the 1 year trading range for Revvity share price?
Revvity has traded in the range of US$ 97,315 to US$ 133,96 during the past year
What is the PE ratio of Revvity?
The price to earnings ratio of Revvity is 21,73
What is the cash to sales ratio of Revvity?
The cash to sales ratio of Revvity is 5,48
What is the reporting currency for Revvity?
Revvity reports financial results in USD
What is the latest annual turnover for Revvity?
The latest annual turnover of Revvity is USD 2,75B
What is the latest annual profit for Revvity?
The latest annual profit of Revvity is USD 693,09M
What is the registered address of Revvity?
The registered address for Revvity is 45 WILLIAM STREET, WALTHAM, MASSACHUSETTS, 02481
What is the Revvity website address?
The website address for Revvity is www.perkinelmer.com
Which industry sector does Revvity operate in?
Revvity operates in the ENGINEERING SERVICES sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TGITriumph Group Inc
US$ 25,11
(33,99%)
20,86M
MXMagnachip Semiconductor Corp
US$ 4,585
(13,21%)
1,45M
OKLOOklo Inc
US$ 45,97
(10,48%)
32,57M
IHSIHS Holding Limited
US$ 3,59
(9,45%)
494,01k
GROVGrove Collaborative Holdings Inc
US$ 1,55
(8,39%)
243,34k
INRInfinity Natural Resources Inc
US$ 21,83
(-43,53%)
757,47k
OMIOwens and Minor Inc
US$ 9,235
(-35,15%)
5,95M
ANVSAnnovis Bio Inc
US$ 3,28
(-32,65%)
3,56M
SRIStoneridge Inc
US$ 4,38
(-15,28%)
445,15k
SUPSuperior Industries International
US$ 1,78
(-14,83%)
347,04k
FFord Motor Company
US$ 9,895
(-1,84%)
117,81M
NIONIO Inc
US$ 4,29
(-0,69%)
59,46M
TAT&T Inc
US$ 24,25
(2,19%)
57,67M
SNAPSnap Inc
US$ 11,18
(-0,97%)
55,24M
BTEBaytex Energy Corporation
US$ 2,34
(-2,50%)
52,95M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NYSE
RVTY
Revvity
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces